# Sulphadoxine-Pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Uganda

> **NCT01184911** · PHASE4 · WITHDRAWN · sponsor: **University of California, San Francisco**

## Conditions studied

- Intermittent Preventive Treatment
- Placental Malaria

## Interventions

- **DRUG:** Sulfadoxine-pyrimethamine

## Key facts

- **NCT ID:** NCT01184911
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-10
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Research plan changed; no longer conducting clinical trial.
- **Last updated:** 2015-03-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01184911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01184911, "Sulphadoxine-Pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Uganda". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01184911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*